These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2546472)

  • 41. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.
    Phair J; Muñoz A; Detels R; Kaslow R; Rinaldo C; Saah A
    N Engl J Med; 1990 Jan; 322(3):161-5. PubMed ID: 1967190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD4+ cells and CD4+ percent as risk markers for Pneumocystis carinii pneumonia (PCP): implications for primary PCP prophylaxis.
    Lidman C; Berglund O; Tynell E; Lindbäck S
    Scand J Infect Dis; 1992; 24(2):157-60. PubMed ID: 1353633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gammadelta T cells increase with Mycobacterium avium complex infection but not with tuberculosis in AIDS patients.
    Pellegrin JL; Taupin JL; Dupon M; Ragnaud JM; Maugein J; Bonneville M; Moreau JF
    Int Immunol; 1999 Sep; 11(9):1475-8. PubMed ID: 10464168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Idiopathic CD4+ T-lymphocytopenia--four patients with opportunistic infections and no evidence of HIV infection.
    Duncan RA; von Reyn CF; Alliegro GM; Toossi Z; Sugar AM; Levitz SM
    N Engl J Med; 1993 Feb; 328(6):393-8. PubMed ID: 8093636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex.
    Pinching AJ; Helbert M; Peddle B; Robinson D; Janes K; Gor D; Jeffries DJ; Stoneham C; Mitchell D; Kocsis AE
    J Infect; 1989 Jan; 18 Suppl 1():33-40. PubMed ID: 2521663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
    Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
    Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
    Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
    Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dysfunction of natural killer cells in human immunodeficiency virus-infected children with or without Pneumocystis carinii pneumonia.
    Bonagura VR; Cunningham-Rundles SL; Schuval S
    J Pediatr; 1992 Aug; 121(2):195-201. PubMed ID: 1353523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
    ; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
    Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opportunistic infections update.
    Proj Inf Perspect; 1998 Apr; (24):17-9. PubMed ID: 11365715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pulmonary complications in HIV-positive patients with minimal immune deficiency].
    Jacobi V; Kirchner J; Thalhammer A
    Rontgenpraxis; 1995 Sep; 48(9):254-8. PubMed ID: 7482045
    [No Abstract]   [Full Text] [Related]  

  • 54. A comparative study of transfusion-acquired human immunodeficiency virus-infected children with and without disseminated Mycobacterium avium complex.
    Gleason-Morgan D; Church JA; Ross LA
    Pediatr Infect Dis J; 1994 Jun; 13(6):484-8. PubMed ID: 7915834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
    JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection.
    Hughes MA; Parisi M; Grossman S; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1423-6. PubMed ID: 16029802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Relationship between T-subsets and clinical aspects of HIV-associated diseases].
    Fuchs M; Stadler BM; Malinverni R; de Weck AL; Pichler WJ
    Schweiz Med Wochenschr; 1991 Jan; 121(3):57-66. PubMed ID: 1671535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-infection by Cryptococcus neoformans and Mycobacterium avium intracellulare in AIDS. Clinical and epidemiological aspects.
    Arastéh K; Cordes C; Futh U; Grosse G; Dietz E; Staib F
    Mycopathologia; 1997-1998; 140(3):115-20. PubMed ID: 9691498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Racial differences in rate of CD4 decline in HIV-1-infected homosexual men.
    Easterbrook PJ; Farzadegan H; Hoover DR; Palenicek J; Chmiel JS; Kaslow RA; Saah AJ
    AIDS; 1996 Sep; 10(10):1147-55. PubMed ID: 8874633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.